1. Albrightson-Winslow CR, Brickson B, King A, Olivera D, Short B, Saunders C, Badger AM (1990) Beneficial effects of long-term treatment with SK&F 105685 in murine lupus nephritis. J Pharmacol Exp Ther 255: 382–387
2. Anderson K (1999) Advances in the biology of multiple myeloma: therapeutic applications. Semin Oncol 26: 10–22
3. Anderson KC (2004) Bortezomib therapy for myeloma. Curr Hematol Rep 3: 65
4. Badger AM, Albrightson-Winslow CR, Kupiec-Weglinski JW (1991) SK&F 105685: a novel immunosuppressive compound with efficacy in animal models of autoimmunity and transplantation. Transplant Proc 23: 194–195
5. Badger AM, Dimartino MJ, Talmadge JE, Picker DH, Schwartz DA, Dorman JW, Mirabelli CK, Hanna N (1989) Inhibition of animal models of autoimmune disease and the induction of non-specific suppressor cells by SK&F 105685 and related azaspiranes. Int J Immunopharmacol 11: 839–846